Hayashi, Tomoyuki Yamashita, Taro Terashima, Takeshi Suda, Tsuyoshi Okada, Hikari Asahina, Yoshiro Hayashi, Takehiro Hara, Yasumasa Nio, Kouki Sunagozaka, Hajime Takatori, Hajime Arai, Kuniaki Sakai, Yoshio Yamashita, Tatsuya Mizukoshi, Eishiro Honda, Masao Kaneko, Shuichi Additional file 2: Figure S2. of Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study Comparison of serum IL-5, CXCL9, and VGEF-A levels between long survivors and non-long survivors in the 2 cohorts. (PDF 117 kb) Hepatocellular carcinoma;Sorafenib;Hepatic arterial infusion chemotherapy;Cytokine;Chemokine;Growth factor 2017-12-19
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_Figure_S2_of_Serum_cytokine_profiles_predict_survival_benefits_in_patients_with_advanced_hepatocellular_carcinoma_treated_with_sorafenib_a_retrospective_cohort_study/5722183
10.6084/m9.figshare.5722183.v1